Molnupiravir Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Molnupiravir Capsule (capsule) from Merck Sharp & Dohme LLC with status To Be Discontinued. The shortage was first posted on Oct 20, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Merck Sharp & Dohme LLC
- Package NDC
- 0006-5055-07
- Dosage Form
- Capsule
- Presentation
- Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)
- Initial Posting
- Oct 20, 2026